| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis
|
Bethel, M Angelyn
|
|
2018
|
6 |
2 |
p. 105-113
|
article
|
| 2 |
Correction to Cover. Lancet Diabetes Endocrinol 2018; 6: (1)
|
|
|
2018
|
6 |
2 |
p. e2
|
article
|
| 3 |
Correction to Lancet Diabetes Endocrinol 2018; 6: 130–42
|
|
|
2018
|
6 |
2 |
p. e2
|
article
|
| 4 |
Cystic-fibrosis-related diabetes: time for oral drugs?
|
Moran, Antoinette
|
|
2018
|
6 |
2 |
p. 85-87
|
article
|
| 5 |
Diabetes and adiposity: a heavy load for cancer
|
Park, Yikyung
|
|
2018
|
6 |
2 |
p. 82-83
|
article
|
| 6 |
Diabetes structured self-management education programmes: a narrative review and current innovations
|
Chatterjee, Sudesna
|
|
2018
|
6 |
2 |
p. 130-142
|
article
|
| 7 |
Distal technologies and type 1 diabetes management
|
Duke, Danny C
|
|
2018
|
6 |
2 |
p. 143-156
|
article
|
| 8 |
Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank
|
Thomas, Nicholas J
|
|
2018
|
6 |
2 |
p. 122-129
|
article
|
| 9 |
Genetics and biobanks converge to resolve a vexing knowledge gap in diabetes
|
Florez, Jose C
|
|
2018
|
6 |
2 |
p. 87-89
|
article
|
| 10 |
GLP-1 receptor agonists: differentiation within the class
|
Taylor, Simeon I
|
|
2018
|
6 |
2 |
p. 83-85
|
article
|
| 11 |
Has the UK really become iodine sufficient?
|
Bath, Sarah C
|
|
2018
|
6 |
2 |
p. 89-90
|
article
|
| 12 |
Jane Speight: tackling diabetes and its stigma Down Under
|
Cavanaugh, Ray
|
|
2018
|
6 |
2 |
p. 94
|
article
|
| 13 |
Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: a multicentre, open-label, randomised trial
|
Ballmann, Manfred
|
|
2018
|
6 |
2 |
p. 114-121
|
article
|
| 14 |
Research digest: progress in microvascular complications
|
Sattar, Naveed
|
|
2018
|
6 |
2 |
p. 93
|
article
|
| 15 |
Retracted: Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment
|
Pearson-Stuttard, Jonathan
|
|
2018
|
6 |
2 |
p. 95-104
|
article
|
| 16 |
Tackling childhood obesity: a step in the right direction
|
The Lancet Diabetes & Endocrinology,
|
|
2018
|
6 |
2 |
p. 81
|
article
|
| 17 |
Technology and chronic disease management
|
Gunasekeran, Dinesh Visva
|
|
2018
|
6 |
2 |
p. 91
|
article
|
| 18 |
Technology and chronic disease management – Authors' reply
|
Chatterjee, Sudesna
|
|
2018
|
6 |
2 |
p. 91-92
|
article
|
Journal description